V
Vor Biopharma Inc
NASDAQ:VOR
Vor Biopharma Inc
NASDAQ:VOR
Price:
12.78
USD
-2.22%
Market Closed
Market Cap:
$530.6m
Balance Sheet
Balance Sheet Decomposition
Vor Biopharma Inc
Vor Biopharma Inc
Balance Sheet Decomposition is not available for
Vor Biopharma Inc
Vor Biopharma Inc
Balance Sheet
Vor Biopharma Inc
Vor Biopharma Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1
|
7
|
49
|
120
|
58
|
31
|
82
|
|
| Cash Equivalents |
1
|
7
|
49
|
120
|
58
|
31
|
82
|
|
| Short-Term Investments |
0
|
0
|
0
|
88
|
173
|
106
|
10
|
|
| Other Current Assets |
0
|
1
|
1
|
7
|
7
|
4
|
5
|
|
| Total Current Assets |
1
|
8
|
49
|
214
|
237
|
141
|
97
|
|
| PP&E Net |
0
|
1
|
22
|
23
|
57
|
50
|
42
|
|
| PP&E Gross |
0
|
1
|
22
|
23
|
57
|
50
|
42
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
2
|
5
|
8
|
11
|
|
| Other Long-Term Assets |
0
|
2
|
5
|
6
|
5
|
7
|
5
|
|
| Total Assets |
1
N/A
|
10
+880%
|
76
+674%
|
243
+220%
|
299
+23%
|
198
-34%
|
143
-28%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
2
|
2
|
2
|
1
|
2
|
|
| Accrued Liabilities |
1
|
1
|
7
|
8
|
11
|
15
|
17
|
|
| Short-Term Debt |
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
3
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
8
|
2
|
10
|
10
|
13
|
16
|
19
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
17
|
16
|
36
|
32
|
28
|
|
| Total Liabilities |
8
N/A
|
2
-72%
|
28
+1 155%
|
26
-5%
|
49
+86%
|
47
-3%
|
46
-2%
|
|
| Equity | ||||||||
| Common Stock |
0
|
25
|
107
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
7
|
18
|
61
|
130
|
222
|
340
|
457
|
|
| Additional Paid In Capital |
0
|
1
|
2
|
346
|
474
|
491
|
554
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
7
N/A
|
8
N/A
|
48
+536%
|
216
+348%
|
251
+16%
|
151
-40%
|
97
-36%
|
|
| Total Liabilities & Equity |
1
N/A
|
10
+880%
|
76
+674%
|
243
+220%
|
299
+23%
|
198
-34%
|
143
-28%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
3
|
3
|
6
|
|
Switch to:
Switch to:
See Also
Discover More
